Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
August 28, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-030698.pdf 0001628280-23-030698.rtf 0001628280-23-030698.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 25, 2023	8-K	Report of unscheduled material events or corporate event	0001517022-23-000032.pdf 0001517022-23-000032.rtf 0001517022-23-000032.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 17, 2023	8-K	Report of unscheduled material events or corporate event	0001517022-23-000029.pdf 0001517022-23-000029.rtf 0001517022-23-000029.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 11, 2023	8-K	Report of unscheduled material events or corporate event	0001517022-23-000027.pdf 0001517022-23-000027.rtf 0001517022-23-000027.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	0001517022-23-000025.pdf 0001517022-23-000025.rtf 0001517022-23-000025.xls View HTML
August 1, 2023	8-K	Report of unscheduled material events or corporate event	0001517022-23-000023.pdf 0001517022-23-000023.rtf 0001517022-23-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 1, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-006088.pdf 0001562180-23-006088.rtf 0001562180-23-006088.xls View HTML
July 18, 2023	8-K	Report of unscheduled material events or corporate event	0001517022-23-000019.pdf 0001517022-23-000019.rtf 0001517022-23-000019.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 18, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001562180-23-005953.pdf 0001562180-23-005953.rtf 0001562180-23-005953.xls View HTML
June 13, 2023	8-K	Report of unscheduled material events or corporate event	0001517022-23-000017.pdf 0001517022-23-000017.rtf 0001517022-23-000017.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax